Abstract
Fatty acid biosynthesis is essential for bacterial survival. In recent years, components of this biosynthetic pathway have aroused wide concern. β-Ketoacyl-acyl carrier protein synthase III (FabH) is a particularly attractive target which catalyzes the initial step of fatty acid biosynthesis. In this review, fatty acid biosynthesis, recent advances in the research of FabH as well as related inhibitors are reviewed. Finally, we also discuss the prospect and developmental trend of FabH inhibitors as anti-bacterial agents.
Keywords: anti-bacterial agents, fatty acid synthase (FAS), FabH, FabH inhibitors, Alkyl-CoA disulfides, Thiolactomycin derivatives, 1,2-Dithiole-3-(thi)ones derivatives, Dithiole-3-(thi)ones derivatives, Cerulenin derivatives, Indole derivatives, Benzoylaminobenzoic acid derivatives, Alkylsulfonyl derivatives, Thiazolidine-2-one 1, 1-dioxide derivatives
Current Medicinal Chemistry
Title: Advances in the Research of β-Ketoacyl-ACP Synthase III (FabH) Inhibitors
Volume: 19 Issue: 8
Author(s): H. -J. Zhang, Z. -L. Li and H. -L. Zhu
Affiliation:
Keywords: anti-bacterial agents, fatty acid synthase (FAS), FabH, FabH inhibitors, Alkyl-CoA disulfides, Thiolactomycin derivatives, 1,2-Dithiole-3-(thi)ones derivatives, Dithiole-3-(thi)ones derivatives, Cerulenin derivatives, Indole derivatives, Benzoylaminobenzoic acid derivatives, Alkylsulfonyl derivatives, Thiazolidine-2-one 1, 1-dioxide derivatives
Abstract: Fatty acid biosynthesis is essential for bacterial survival. In recent years, components of this biosynthetic pathway have aroused wide concern. β-Ketoacyl-acyl carrier protein synthase III (FabH) is a particularly attractive target which catalyzes the initial step of fatty acid biosynthesis. In this review, fatty acid biosynthesis, recent advances in the research of FabH as well as related inhibitors are reviewed. Finally, we also discuss the prospect and developmental trend of FabH inhibitors as anti-bacterial agents.
Export Options
About this article
Cite this article as:
-J. Zhang H., -L. Li Z. and -L. Zhu H., Advances in the Research of β-Ketoacyl-ACP Synthase III (FabH) Inhibitors, Current Medicinal Chemistry 2012; 19 (8) . https://dx.doi.org/10.2174/092986712799320484
DOI https://dx.doi.org/10.2174/092986712799320484 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Psychotic (Delusional) Major Depression in the Elderly: A Review
Current Psychiatry Reviews From the Old Immunitas to the Modern Immunity: Do We Need a New Name for the Immune System?
Current Immunology Reviews (Discontinued) Transcranial Magnetic Stimulation of Degenerating Brain: A Comparison of Normal Aging, Alzheimer’s, Parkinson’s and Huntington's Disease
Current Alzheimer Research Sleep-Disordered Breathing and Cardiovascular Disease: Exploring Pathophysiology and Existing Data
Current Respiratory Medicine Reviews Identification of Disease-Relevant Genes for Molecularly-Targeted Drug Discovery
Current Cancer Drug Targets Therapeutic Nucleic Acids
Recent Patents on Regenerative Medicine Advances in the Development of Virus-Like Particles as Tools in Medicine and Nanoscience
Current Chemical Biology Influenza Viruses: Basic Biology and Potential Drug Targets
Infectious Disorders - Drug Targets Synaptic Activity-Regulated Wnt Signaling in Synaptic Plasticity, Glial Function and Chronic Pain
CNS & Neurological Disorders - Drug Targets Recent Progress in the Identification and Clinical Evaluation of Inhibitors of the Mitotic Kinesin KSP
Current Topics in Medicinal Chemistry Oxycodone/Naloxone in the Management of Patients with Pain and Opioid–Induced Bowel Dysfunction
Current Drug Targets Recent Advances in Pathophysiology of Traumatic Brain Injury
Current Neuropharmacology Current Understanding of the Interplay Between Catechol-OMethyltransferase Genetic Variants, Sleep, Brain Development and Cognitive Performance in Schizophrenia
CNS & Neurological Disorders - Drug Targets The Role of P2X Receptors in Bone Biology
Current Medicinal Chemistry Formulation, Standardization, and a Preliminary Before-After Clinical Trial on Effect of a Traditional Herbal Formula (Maqliasa) on Manifestations of Ulcerative Colitis
Current Drug Discovery Technologies Aquaporins and Glia
Current Neuropharmacology Characterizing the Binding of Angiotensin Converting Enzyme I Inhibitory Peptide to Human Hemoglobin: Influence of Electromagnetic Fields
Protein & Peptide Letters Introduction: P2 Receptors
Current Topics in Medicinal Chemistry 1, 2-Benzisoxazole: A Privileged Structure with a Potential for Polypharmacology
Current Pharmaceutical Design Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids
Medicinal Chemistry